Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, 89bio (ETNB) has a market cap of $0.88 billion USD. According to our data, 89bio is ranked No.5207 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.88 B |
-21.32%
|
| Dec 31, 2024 | $1.12 B |
-29.99%
|
| Dec 29, 2023 | $1.60 B |
-12.25%
|
| Dec 30, 2022 | $1.83 B |
-2.60%
|
| Dec 31, 2021 | $1.88 B |
-46.37%
|
| Dec 31, 2020 | $3.50 B |
-7.30%
|
| Dec 31, 2019 | $3.77 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Madrigal Pharmaceuticals
MDGL
|
$6.77 B |
-0.324 B
|
USA
|
 Viking Therapeutics
VKTX
|
$2.59 B |
-0.000 M
|
USA
|
 Akero Therapeutics
AKRO
|
$3.03 B |
0.000 M
|
USA
|
 Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
Israel
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Genfit
GNFT
|
$0.18 B |
0.000 M
|
France
|
 Arrowhead Pharmaceuticals
ARWR
|
$1.77 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 FibroGen
FGEN
|
$29.89 M |
0.000 M
|
USA
|
 Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
Canada
|
| Market Cap | = | ETNB Stock Price | * | ETNB Shares Outstanding |
| = | $6.05 | * | 0.15 B | |
| = | $0.88 B |